Re: Presentation
in response to
by
posted on
Nov 03, 2017 10:58AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"Great if both continue to float but the results seem to give Zenith the edge especially as they are working with known drugs."
An edge in what sense?